About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Impact of A. Lumbricoides on Pulmonary Aspergillosis Development

Impact of A. Lumbricoides on Pulmonary Aspergillosis Development

NCT05783544·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Abdurakhim Dr Toychiev, PhD
CONTACT
+998901358977 abdurahim1988@gmail.com
Svetlana Dr Osipova, PhD
CONTACT
+998712774008 svetosip7@mail.ru

Lead

Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan

Age

30–100

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

COPD patients
COPD patients with aspergillosis
COPD patients with ascariasis
COPD patients with mix-infection
Healthy individuals (controls)

You may not be if

COPD patients with other autoimmune diseases
COPD patients with oncological diseases
COPD patients with other co-infections

The record

StatusUnknown

PhaseNo phase

Taking part200

StartedMay 2015

UpdatedAug 1, 2023

Conditions

COPD Exacerbation Acute Ascaris Lumbricoides Infection Chronic Pulmonary Aspergillosis

Where1

Research institute of epidemiology, microbiology and infectious diseases
Tashkent, Uchtepa, Uzbekistan